| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/31/2004 | CN1143859C Camptothecin derivative and its preparation |
| 03/31/2004 | CN1143858C 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines |
| 03/31/2004 | CN1143857C Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors |
| 03/31/2004 | CN1143855C I (ortho)-anthranilamide derivatives as anti-coagulants |
| 03/31/2004 | CN1143854C Novel 2-(iminomethyl) amino-phenyl derivatives,the preparation thereof, application as medicines and pharmaceutical compositions containing same |
| 03/31/2004 | CN1143853C Preparing method for anti-viral compounds |
| 03/31/2004 | CN1143852C Ideno-, haphto- and benzocyclohepta dihydrothizole derivatives, the production thereof and their use as anorectic medicaments |
| 03/31/2004 | CN1143851C Penicillene compounds and derivatives therefrom |
| 03/31/2004 | CN1143850C Menispermum dahuricum dc.extract,the extractive process and the application thereof |
| 03/31/2004 | CN1143848C 2-arylethyl-(piperidin-4-ylmethyl) amine derivatives as muscarinic receptor antagonists |
| 03/31/2004 | CN1143847C Thio-oxindole derivatives |
| 03/31/2004 | CN1143688C Triacetin as transdermal permeation enhancer |
| 03/31/2004 | CN1143687C Plaster for treating cervical vertebra hyperplasia |
| 03/31/2004 | CN1143685C Pterygium eliminating liquid |
| 03/31/2004 | CN1143683C Exterior-applied black plaster for treating bone diseases and its preparing process |
| 03/31/2004 | CN1143682C Medicine for treating cold and its preparing process |
| 03/31/2004 | CN1143680C Method of enhancing bioavailability of fexofenadine and its derivatives |
| 03/31/2004 | CN1143679C Method and material for treating and preventing mucosal tissue inflammation |
| 03/31/2004 | CN1143678C Use of VC-magnesium phosphate ester in preparation of medication for constipation |
| 03/31/2004 | CN1143677C Use of nitrophenyl salicyl amine as spermicide |
| 03/31/2004 | CN1143676C Application of sodium taurocholate as synergist for antituberculosis antibiotic |
| 03/31/2004 | CN1143675C Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analgetics |
| 03/31/2004 | CN1143674C Refractory vasculitis therapeutic agent |
| 03/31/2004 | CN1143672C Pharmaceutical compositions comprising uridine triphosphate |
| 03/31/2004 | CN1143668C Ascorbyl-phosphoryl-cholesterol |
| 03/30/2004 | US6713651 β2-adrenergic receptor agonists |
| 03/30/2004 | US6713650 ABCA-1 elevating compounds |
| 03/30/2004 | US6713638 2-amino-3-aroyl-4,5 alkylthiophenes: agonist allosteric enhancers at human A1 adenosine receptors |
| 03/30/2004 | US6713635 As chemical intermediates used for the preparation of s-alpha-ethyl-2-oxo-1-pyrrolidine acetamide |
| 03/30/2004 | US6713633 Compounds capable of cleaving double-stranded DNA and method of utilization of the same |
| 03/30/2004 | US6713627 For receptor antagonists in treatment of schizolphrenia, anxiety, variant angina, anorexia vervosa, raynaud's phenomenon, intermittent claudication, coronary or peripheral vasospasms, fibromyalgia, cardiac arrhythmia's, and thrombosis |
| 03/30/2004 | US6713623 Useful as intermediates in the synthesis of biologically active compounds |
| 03/30/2004 | US6713621 Chimeric compositions having multi-modalities are also provided which can affect a plurality of gene functions by interfering with splicing or translation as well as transcription |
| 03/30/2004 | US6713607 Effector proteins of Rapamycin |
| 03/30/2004 | US6713517 Using n-(2-diethylamino-ethyl)-4-amino-3-chlorobenzamide |
| 03/30/2004 | US6713515 Administering benzyl, naphthyl acid derivatives |
| 03/30/2004 | US6713513 Method for treating cartilage related diseases |
| 03/30/2004 | US6713510 Amide and ester derivatives |
| 03/30/2004 | US6713509 High molecular weight crosslinked acrylic acid polymer, dibasic calcium phosphate and phosphodiesterase isozyme denominated 4 inhibitor; chronic obstructive pulmonary disease (copd) |
| 03/30/2004 | US6713508 Such as 7-(3-(3-trifluoromethyl-7-propyl-6-benz-(4,5)-isoxazoloxy)propoxy)-2 -ethylchromane-2-carboxylic acid which are potent agonists of peroxisome proliferator activated receptor |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | US6713506 Inhibiting proteasomal chymotrypsin-like activity |
| 03/30/2004 | US6713505 Such as n-(2-((3-(aminooxoacetyl)-2-ethylbenzo(b)thiophen-4-yl)oxy) acetyl)glycine; secretory phospholipase a2 (spla2) |
| 03/30/2004 | US6713502 Anti-infectives |
| 03/30/2004 | US6713501 Supplement for dialysis patients |
| 03/30/2004 | US6713500 Agent for controlling animal diseases caused by parasites |
| 03/30/2004 | US6713499 Adenosine receptor agonist |
| 03/30/2004 | US6713498 Method for treating glaucoma VI |
| 03/30/2004 | US6713497 Reducing side effects from excess gamma amino butyric acid (gaba) in central nervous system |
| 03/30/2004 | US6713495 Magnesium omeprazole |
| 03/30/2004 | US6713493 Of neurological diseases involving attack of the pyramidal pathway such as: amyotrophic lateral sclerosis, progressive spinal muscular atrophy, infantile muscular atrophy, primary lateral sclerosis and cerebrovascular accident |
| 03/30/2004 | US6713492 N-acyloxylated cycloalkyl compounds, composition containing the same and methods of use therefor |
| 03/30/2004 | US6713491 For use as medicine for antagonising the effects of excitatory amino acids upon the nmda receptor complex |
| 03/30/2004 | US6713490 6-(2-(4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl)-1-hydroxy -ethyl)-3,4-dihydro-2(1h)-quinolinone; reduced inhibitory activity at herg (human ether-a-go-go related gene) potassium channel |
| 03/30/2004 | US6713489 Treatment of atherosclerosis, obesity, diabetes, hyperlipidemia, hyperlipoproteinemia, hypercholesterolemia, hypertriglyceridemia, hypoalphalipoproteinemia, pancreatitis, myocardial infarction, stroke, restenosis, or syndrome x |
| 03/30/2004 | US6713488 Neutral antagonists and use thereof in treating drug abuse |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713485 Antiproliferative agents; side effect reduction |
| 03/30/2004 | US6713484 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family |
| 03/30/2004 | US6713483 [1,2,3]-triazolo[4,5-d] pyrimidine compounds |
| 03/30/2004 | US6713482 Such as (e)-1-(2-pyridyl)-2-styryl-1h-benzimidazole; antiinflammatory and analgesic agents; prostaglandin inhibitors |
| 03/30/2004 | US6713480 Phenylahistin and the phenylahistin analogs, a new class of anti-tumor compounds |
| 03/30/2004 | US6713478 Cyclocarbamate derivatives as progesterone receptor modulators |
| 03/30/2004 | US6713476 Substituted cycloalkyls as inhibitors of a beta protein production |
| 03/30/2004 | US6713473 6-carbamate-1,2,3,4-tetrahydrocarbazole derivatives; affinity for neuropeptide y receptors |
| 03/30/2004 | US6713470 Method of treatment |
| 03/30/2004 | US6713469 Chromium picolinate compositions and uses thereof |
| 03/30/2004 | US6713467 Anticoagulants in treating and preventing cardiovascular diseases, as anti-inflammatory agents, and metastasis inhibitors in treating cancer |
| 03/30/2004 | US6713465 Salt of 5-alpha-pregn-16-en-3-ol-20-one-3-sulfate ester; progestational agent |
| 03/30/2004 | US6713464 Derivatives of 3,3-diphenylpropylamines |
| 03/30/2004 | US6713463 Methods and compositions for treating and preventing mucositis |
| 03/30/2004 | US6713462 Quinolinones and uses thereof |
| 03/30/2004 | US6713461 Eletriptan and sulphobutylether-beta-cyclodextrin; well tolerated intranasal delivery; bioavailability; fast acting |
| 03/30/2004 | US6713459 Glucan sulphate, glucan phosphate and/or scleroglucan |
| 03/30/2004 | US6713456 Nucleozymes |
| 03/30/2004 | US6713455 6-O-carbamate-11,12-lacto-ketolide antimicrobials |
| 03/30/2004 | US6713454 Prodrugs of etoposide and etoposide analogs |
| 03/30/2004 | US6713451 Insulin-like growth factor agonist molecules |
| 03/30/2004 | US6713448 Substantially pure glycopeptide antibiotics AC-98-1; AC-98-2; AC-98-3; AC-98-4 and AC-98-5 |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713268 Methods of identifying ocular hypotensive compounds having reduced hyperpigmentation |
| 03/30/2004 | US6713092 Withania Somnifera composition, method for obtaining same and pharmaceutical, nutritional and personal care formulations thereof |
| 03/30/2004 | US6713090 Apparatus and method for preparing microparticles |
| 03/30/2004 | US6713089 Under acidic conditions; nonsteroid antiinflammatory nsaid; crushing strength |
| 03/30/2004 | US6713086 Side effect reduction, treatment of migraine, epilepsy, mania associated with a bipolar disorders, once a day dosage, an oral osmotic pump formulations, containing hydroxypropyl-methyl cellulose |
| 03/30/2004 | US6713074 Cosmetic composition and method |
| 03/30/2004 | US6713048 Δ9 tetrahydrocannabinol (Δ9 THC) solution metered dose inhalers and methods of use |
| 03/30/2004 | US6713043 Altering a pathway of fatty acid synthesis in a bacterium with a phenol derivative |
| 03/30/2004 | US6712819 Mating insertion instruments for spinal implants and methods of use |
| 03/30/2004 | CA2330217C Therapeutic agent for a cancer and method of screening the same and health-care auxiliary food |
| 03/30/2004 | CA2318359C Polymeric compounds and methods of formulating same |
| 03/30/2004 | CA2314115C Process for the optical resolution of the racemic 6-(4-amino-phenyl)-5- methyl-pyridazin-3(2h)one |
| 03/30/2004 | CA2305933C (poly)thia-alcynoic compounds and their derivatives, compositions containing them and their uses |
| 03/30/2004 | CA2304110C Theophylline sustained release tablet |
| 03/30/2004 | CA2296231C Composition and method for treating common viral infections |
| 03/30/2004 | CA2291222C Naphthyridinones for inhibiting protein tyrosine kinase and cell cycle kinase mediated cellular proliferation |
| 03/30/2004 | CA2278687C 5-aroylnaphthalene derivatives |
| 03/30/2004 | CA2277165C Purification and/or concentration of dna by cross-flow filtration, separation of endotoxins from a nucleic acid preparation |
| 03/30/2004 | CA2264513C Substituted benzocycloheptapyridine derivatives useful for inhibition of farnesyl protein transferase |
| 03/30/2004 | CA2251633C Sunscreen composition comprising a solid elastomeric organopolysiloxane |